Copyright © 2021. Inderes Oyj. All rights reserved.
Käyttäjätili

Hei anonyymi!

Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.

Luo tili

Onko sinulla jo Inderes-tili?

Carasent ASA

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
19.3.
2023
Svein Martin Bjørnstad, CFO in Carasent ASA, has through his wholly-owned
company Birgen Invest II AS, acquired 150,000 shares at NOK 13.76 per share.
Following this trade Svein Martin Bjørnstad and associated companies holds in
total 280,249 shares in Carasent ASA.
Tiedotteet
20.2.
2023
Board member in Carasent ASA, Ulrika Cederskog Sundling, has today acquired
6,000 shares in Carasent ASA at an average share price of NOK 16,79 per share.
Following this trade her total shareholding in the Company is 6,000 shares.
Tiedotteet
16.2.
2023

Redeye updates its estimates following Carasent’s Q4 2022 report, which showed stronger growth than what we had anticipated. Moreover, the organic growth rate pace increased from the previous quarter. Investments still weighed down near-term margins, but management signaled that it seeks to slow down new hires and start scaling margins again, in a few quarters' time, to our understanding.

Read more and download the Research Update.

Tiedotteet
15.2.
2023
Attached please find Carasent Q4 and FY 2022 Financial Results and Presentation.
Tiedotteet
14.2.
2023
Carasent ASA will present its Q4 and FY 2022 Financial Results as a webcast on
February 15, at 8:00 a.m.

Please use the following link for the webcast:
https://channel.royalcast.com/landingpage/hegnarmedia/20230215_3/

Welcome.
Tiedotteet
19.1.
2023
Attached please find the proposal from the Company's Nomination Committee to the
Annual Shareholder Meeting.
Tiedotteet
4.1.
2023
Financial calendar for Carasent ASA

FINANCIAL YEAR 2022


15.02.2023 - Quarterly Report - Q4


FINANCIAL YEAR 2023

14.07.2023 - Half-yearly Report
31.03.2023 - Annual Report
03.05.2023 - Annual General Meeting

04.05.2023 - Quarterly Report - Q1
26.10.2023 - Quarterly Report - Q3
15.02.2024 - Quarterly Report - Q4



This information is published pursuant to the requirements set out in the
Continuing obligations.
Tiedotteet
7.11.
2022

Redeye updates its estimates following Carasent’s Q3 report and the acquisitions of HPI and Confrere. The Q3 report came in below our estimates, and we are thus revising our near to medium-term estimates as a consequence.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

Muut analyysit
7.11.
2022

Redeye updates its estimates following Carasent’s Q3 report and the acquisitions of HPI and Confrere. The Q3 report came in below our estimates, and we are thus revising our near to medium-term estimates as a consequence.

Tiedotteet
28.10.
2022
The new CEO Daniel Øhman has bought 8,500 shares in Carasent ASA for a total
amount of NOK 144,585 at an average share price of NOK 17.01 per share. Total
holding after this trade is 12,221 shares.

For further informatio please contact:
Svein Martin Bjørnstad, CFO, tel: +47 97969493

Carasent ASA